Search
Now showing items 1-10 of 35
SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)
Philippen, Angela et al. (2010)
Wissenschaftlicher Artikel
Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways
Kohlmann, A. et al. (2010)
Wissenschaftlicher Artikel
Analysis of t(15;17) Chromosomal Breakpoint Sequences in Therapy-Related Versus De Novo Acute Promyelocytic Leukemia: Association of DNA Breaks with Specific DNA Motifs at PML and RARA Loci
Hasan, Syed Khizer et al. (2010)
Wissenschaftlicher Artikel
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
Hallek, M. et al. (2010)
Wissenschaftlicher Artikel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Döhner, Hartmut et al. (2010)
Wissenschaftlicher Artikel
From pathogenesis to treatment of chronic lymphocytic leukaemia
Zenz, Thorsten et al. (2010)
Wissenschaftlicher Artikel
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)
Zenz, Thorsten et al. (2010)
Wissenschaftlicher Artikel
IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
Paschka, Peter et al. (2010)
Wissenschaftlicher Artikel
Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
Josting, Andreas et al. (2010)
Wissenschaftlicher Artikel
Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells
Idler, Irina et al. (2010)
Wissenschaftlicher Artikel